Has tamoxifen had its day?
Tamoxifen is probably the most important drug in the history of the management of breast cancer and its development is a tribute to cross talk between laboratory scientists and clinical investigators. Its use as adjuvant therapy has led to a decrease of 20–30% in age-adjusted cause-specific mortalit...
সংরক্ষণ করুন:
| প্রকাশিত: | Breast Cancer Res |
|---|---|
| প্রধান লেখক: | |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
BMC
2002
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137937/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12473165/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr536 |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|